A Study to Evaluate Oral Formulations of Tedizolid Phosphate in Healthy Participants (MK-1986-043)
Clinical trial NCT06733688 · COMPLETED
Trial details
- NCT number
- NCT06733688
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2022-04-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.